Medical AI Alliance
Company Index
Medical DevicesKOSDAQ 048870119 approvals

Synergy Innovation Co., Ltd.

Official website

Synergy Innovation, founded in 1998 and KOSDAQ-listed in 2004, manufactures and sells microbial culture media.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1998 and listed on KOSDAQ in 2004, Synergy Innovation manufactures and sells microbial culture media. It supplies microbial culture media, used as reagents for in-vitro diagnostic analyzers and for environmental monitoring in pharmaceutical manufacturing, to hospitals, testing centers, and pharmaceutical companies nationwide, and holds ISO13485 and medical device KGMP certifications. It operates through 7 consolidated subsidiaries across biotechnology, medical, and health functional food divisions, and invests in drug development via subsidiary Neurobiogen, recording cumulative 2025 revenue of KRW 113.1 billion.

Regulatory approvals

data.go.kr

119 Korean MFDS device approvals · 2013–2024

  • MFDSIVD reagents for staining or culturing clinical microbiology2024-08-20
    Product approval · Class 1체외 제신 24-1057 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2023-06-19
    Product approval · Class 1체외 제신 23-940 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-08-18
    Product approval · Class 1체외 제신 22-1149 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-06-23
    Product approval · Class 1체외 제신 22-852 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-01-28
    Product approval · Class 1체외 제신 22-137 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-01-28
    Product approval · Class 1체외 제신 22-136 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-01-28
    Product approval · Class 1체외 제신 22-135 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-01-13
    Product approval · Class 1체외 제신 22-64 호
  • MFDSIVD reagents and media for antibiotic susceptibility2021-12-20
    Product approval · Class 2체외 제인 21-5058 호
  • MFDSIVD reagents and media for antibiotic susceptibility2021-09-17
    Product approval · Class 2체외 제인 21-4815 호
  • MFDSSpecimen transport mediaRevoked2020-11-18
    Product approval · Class 1체외 제신 20-1670 호
  • MFDSSpecimen transport mediaRevoked2020-11-06
    Product approval · Class 1체외 제신 20-1633 호
Show 68 more
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-09-24
    Product approval · Class 1체외 제신 20-1463 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-08-05
    Product approval · Class 1체외 제신 20-1179 호
  • MFDSSpecimen transport media2020-07-16
    Product approval · Class 1체외 제신 20-1086 호
  • MFDSSpecimen transport media2020-06-24
    Product approval · Class 1체외 제신 20-930 호
  • MFDSSpecimen transport media2020-06-17
    Product approval · Class 1체외 제신 20-887 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-03-27
    Product approval · Class 1체외 제신 20-439 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-02-04
    Product approval · Class 1체외 제신 20-140 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-02-03
    Product approval · Class 1체외 제신 20-135 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-02-03
    Product approval · Class 1체외 제신 20-136 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2019-04-19
    Product approval · Class 1체외 제신 19-504 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2019-04-18
    Product approval · Class 1체외 제신 19-498 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2016-07-01
    Product approval · Class 1체외 제신 16-810 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2016-07-01
    Product approval · Class 1체외 제신 16-808 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-10-29
    Product approval · Class 1체외 제신 15-324 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-09-15
    Product approval · Class 1체외 제신 15-141 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-09-15
    Product approval · Class 1체외 제신 15-142 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-06-19
    Product approval · Class 1경인 체외 제신 15-324 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-02-09
    Product approval · Class 1경인 체외 제신 15-66 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-02-09
    Product approval · Class 1경인 체외 제신 15-65 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2014-10-14
    Product approval · Class 1경인 체외 제신 14-580 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2014-08-01
    Product approval · Class 1경인 체외 제신 14-452 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2014-08-01
    Product approval · Class 1경인 체외 제신 14-451 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-08-01
    Product approval · Class 1경인 체외 제신 14-450 호
  • MFDSIVD reagents and media for antibiotic susceptibility2014-02-28
    Product approval · Class 2체외 제인 14-511 호
  • MFDSIVD reagents and media for antibiotic susceptibility2014-02-28
    Product approval · Class 2체외 제인 14-512 호
  • MFDSIVD reagents and media for antibiotic susceptibility2014-02-28
    Product approval · Class 2체외 제인 14-513 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2014-01-08
    Product approval · Class 1경인 체외 제신 14-27 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2014-01-08
    Product approval · Class 1경인 체외 제신 14-20 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-19 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1체외 제신 14-21 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-22 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-23 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-24 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-25 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-26 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-28 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-29 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-677 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-678 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-679 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-680 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-681 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-682 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-667 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-665 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-664 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-662 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-657 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-651 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-648 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-647 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-645 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-643 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-636 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-627 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-628 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-629 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-630 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-631 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-632 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-633 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-634 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-635 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-637 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-638 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-639 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-640 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-641 호

Showing the 80 most recent of 119 records.

Not yet compiled: business overview · products · R&D. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

GC Medical Science Corporation2 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

QuantaMatrix Incorporated2 shared

Established in 2010, listed on KOSDAQ in 2020, QuantaMatrix develops dRAST and QDST antimicrobial susceptibility testing systems.

Aimed Bio Inc.1 shared

KOSDAQ-listed ADC oncology biotech that has out-licensed pipeline candidates to Biohaven, SK Plasma, and Boehringer Ingelheim.

AIOBIO Co., Ltd.1 shared

Develops quantitative fluorescence biomarker technology for oral disease diagnostic devices.

BIONEERCORPORATION1 shared

Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.

Boditech Med Inc.1 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

Ensol Biosciences Inc.1 shared

Ensol Biosciences is a KONEX-listed biotech developing short peptide therapeutics that modulate protein-protein interactions (PPI).

Genomictree Inc.1 shared

Cancer molecular diagnostics company behind the EarlyTect-C stool-based colorectal cancer test using the SDC2 methylation biomarker.

Optipharm.CO.,LTD1 shared

Optipharm, founded in 2000 and KOSDAQ-listed in 2018, provides animal disease diagnostics, animal medicine, and biotech.

PCL. Inc1 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

SD BIOSENSOR INC.1 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

Xcell Therapeutics Inc.1 shared

Xcell Therapeutics develops the domestically produced CellCor™ cell culture media series for cell and gene therapy manufacturing.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition